When East Meets West, Global Cancer Research Improves – China Health Minister
This article was originally published in PharmAsia News
Wearing two hats as a hematologist and China’s health minister, Zhu Chen says basic research and policymaking are interrelated and mutually beneficial.
You may also be interested in...
Oncology Market In China Outpaces Pharma Industry; Targeted Therapies Enjoy Fastest Growth - Citi Research
Once the world's factory, China has seen costs inch up while drug prices are being cut deeply by centralized procurement schemes. As uncertainties mount, companies need to focus on improving process and scale-up technology, suggested industry observers at a JPM panel discussion on innovation and market access challenges.